RVMDW Revolution Medicines, Inc. - Warrant
Revolution Medicines, Inc. - Warrant Hakkında Wikipedia'dan şirket genel bakışı
RVMDW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
RVMDW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $12M | $35M | $29M | $43M | $50M | |
| R&D Expense | $987M | $592M | $423M | $253M | $187M | $132M | $92M | |
| SG&A Expense | $195M | $97M | $76M | $41M | $30M | $21M | $12M | |
| Operating Expenses | $1.18B | $690M | $499M | $294M | $217M | $154M | $104M | |
| Operating Income | $-1.18B | $-690M | $-487M | $-258M | $-188M | $-111M | $-54M | |
| Interest Expense | · | · | · | $0 | $12.0K | $71.0K | $106.0K | |
| Interest Income | $91M | $87M | $47M | $9M | $929.0K | $2M | $2M | |
| Other Non-op | $51M | $89M | $47M | $9M | $917.0K | $2M | $2M | |
| Pretax Income | $-1.13B | $-601M | $-440M | $-249M | $-187M | $-109M | $-52M | |
| Income Tax | $0 | $-753.0K | $-4M | $-420.0K | $0 | $-371.0K | $-4M | |
| Net Income | $-1.13B | $-600M | $-436M | $-249M | $-187M | $-108M | $-48M | |
| EPS (Basic) | $-5.95 | $-3.58 | $-3.86 | $-3.08 | $-2.57 | $-2.01 | · | |
| EPS (Diluted) | $-5.95 | $-3.58 | $-3.86 | $-3.08 | $-2.57 | $-2.01 | · | |
| Shares (Basic) | 190,129,154 | 167,737,672 | 113,149,869 | 80,626,525 | 72,806,079 | 54,874,119 | · | |
| Shares (Diluted) | 190,129,154 | 167,737,672 | 113,149,869 | 80,626,525 | 72,806,079 | 54,874,119 | · | |
| EBITDA | $-1.17B | $-683M | $-487M | $-254M | $-185M | $-108M | · |
Bilanço 24
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $384M | $543M | $696M | $161M | $108M | $104M | $17M | |
| Short-term Investments | $1.64B | $1.75B | $1.16B | $484M | $469M | $336M | $106M | |
| Prepaid Expense | $49M | $38M | $25M | $11M | $7M | $7M | $2M | |
| Current Assets | $2.08B | $2.33B | $1.88B | $660M | $590M | $454M | $134M | |
| PP&E (Net) | $33M | $24M | $23M | $19M | $12M | $9M | $7M | |
| PP&E (Gross) | $62M | $46M | $41M | $33M | $22M | $17M | $13M | |
| Accum. Depreciation | $29M | $22M | $18M | $14M | $11M | $8M | $6M | |
| Goodwill | $15M | $15M | $15M | $15M | $15M | $15M | $15M | |
| Intangibles | $56M | $57M | $58M | $59M | $60M | $61M | $62M | |
| Other Non-current Assets | $15M | $2M | $7M | $3M | $758.0K | $305.0K | $3M | |
| Total Assets | $2.35B | $2.56B | $2.06B | $812M | $738M | $567M | $221M | |
| Accounts Payable | $65M | $54M | $62M | $21M | $14M | $13M | $11M | |
| Accrued Liabilities | $5M | · | · | · | · | · | · | |
| Current Liabilities | $290M | $164M | $144M | $62M | $60M | $47M | $43M | |
| Capital Leases | $142M | $123M | $81M | $57M | $60M | $29M | · | |
| Deferred Tax | $2M | $2M | $3M | $7M | $7M | $7M | $8M | |
| Other Non-current Liabilities | $1M | $670.0K | $1M | $301.0K | $634.0K | $632.0K | $655.0K | |
| Total Liabilities | $723M | $293M | $236M | $127M | $135M | $93M | $68M | |
| Common Stock | $19.0K | $18.0K | $16.0K | $9.0K | $8.0K | $7.0K | · | |
| Retained Earnings | $-2.87B | $-1.74B | $-1.14B | $-701M | $-453M | $-266M | $-157M | |
| AOCI | $3M | $1M | $544.0K | $-2M | $-376.0K | $116.0K | $74.0K | |
| Stockholders' Equity | $1.63B | $2.27B | $1.83B | $685M | $603M | $475M | $-153M | |
| Liabilities + Equity | $2.35B | $2.56B | $2.06B | $812M | $738M | $567M | $221M | |
| Shares Outstanding | 197,001,401 | 185,896,625 | 164,674,594 | 90,411,912 | 74,142,619 | 66,599,748 | 3,292,124 |
Nakit Akışı 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $5M | $4M | $3M | $3M | $2M | |
| Stock-based Comp | $118M | $79M | $62M | $31M | $21M | $9M | $3M | |
| Deferred Tax | $0 | $-738.0K | $-4M | $-420.0K | · | · | · | |
| Amort. of Intangibles | $870.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-cash | $107M | $-42M | · | $-11M | $16M | $-3M | · | |
| Operating Cash Flow | $-898M | $-557M | $-351M | $-224M | $-147M | $-100M | $-50M | |
| CapEx | $16M | $10M | $8M | $11M | $7M | $3M | $3M | |
| Investing Cash Flow | $118M | $-554M | $-343M | $-24M | $-142M | $-234M | $-102M | |
| Stock Issued | $0 | $728M | $324M | $248M | $281M | $420M | · | |
| Net Stock Activity | $0 | $728M | $324M | $248M | $281M | $420M | · | |
| Dividends Paid | · | · | · | · | · | $0 | · | |
| Financing Cash Flow | $622M | $959M | $1.23B | $301M | $294M | $423M | $99M | |
| Net Change in Cash | $-158M | $-152M | $536M | $53M | $5M | $88M | $-53M | |
| Free Cash Flow | $-914M | $-568M | $-358M | $-235M | $-154M | $-103M | · | |
| Levered FCF | · | · | · | $-235M | $-154M | $-103M | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -4207.1% | -730.0% | -639.7% | -257.5% | · | |
| Net Margin | · | · | -3768.3% | -702.9% | -636.6% | -251.6% | · | |
| Pretax Margin | · | · | -3798.7% | -704.1% | -636.6% | -252.5% | · | |
| EBITDA Margin | · | · | -4207.1% | -718.8% | -629.2% | -251.5% | · | |
| ROA | -46.1% | -26.0% | -30.4% | -32.1% | -28.7% | -27.5% | · | |
| ROE | -64.7% | -31.3% | -32.8% | -36.4% | -30.2% | -22.1% | · | |
| ROIC | -72.5% | -30.4% | -26.5% | -37.6% | -31.2% | -23.2% | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.1 | 14.2 | 13.1 | 10.7 | 9.8 | 9.6 | · | |
| Quick Ratio | 7.0 | 14.0 | 12.9 | 10.4 | 9.6 | 9.3 | · | |
| Interest Coverage | · | · | · | · | -15667.3 | -1559.1 | · |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | · |
Büyüme Oranları 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -67.3% | 20.4% | -31.6% | · | · | |
| Revenue CAGR 3Y | · | · | -35.4% | · | · | · | · |
Değerleme (TTM) 11
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $12M | $35M | $29M | $43M | $50M | |
| Net Income TTM | $-1.13B | $-600M | $-436M | $-249M | $-187M | $-108M | $-48M | |
| Market Cap | $158M | · | · | · | · | · | · | |
| P/E | -0.1 | · | · | · | · | · | · | |
| P/B | 0.1 | · | · | · | · | · | · | |
| P / Tangible Book | 0.1 | · | · | · | · | · | · | |
| P / Cash Flow | -0.2 | · | · | · | · | · | · | |
| P / FCF | -0.2 | · | · | · | · | · | · | |
| Earnings Yield | -742.7% | · | · | · | · | · | · | |
| Payout Ratio | · | · | · | · | · | 0.00% | · | |
| Annual Payout | · | · | · | · | · | $0 | · |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $742.0K | $0 | $4M | $7M | $15M | $3M | |
| R&D Expense | $395M | $344M | $295M | $263M | $224M | $206M | $188M | $152M | $135M | $118M | $148M | $108M | $98M | $69M | $66M | $69M | |
| SG&A Expense | $110M | $101M | $67M | $53M | $41M | $35M | $29M | $24M | $22M | $23M | $32M | $16M | $15M | $13M | $11M | $10M | |
| Operating Expenses | $505M | $445M | $362M | $315M | $265M | $241M | $216M | $176M | $157M | $141M | $181M | $123M | $113M | $82M | $77M | $80M | |
| Operating Income | $-505M | $-445M | $-362M | $-315M | $-265M | $-241M | $-216M | $-176M | $-157M | $-141M | $-180M | $-123M | $-109M | $-75M | $-62M | $-77M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Interest Income | $36M | $20M | $21M | $22M | $22M | $25M | $21M | $20M | $21M | $24M | $19M | $11M | $10M | $7M | $5M | $3M | |
| Other Non-op | $-6.0K | $117.0K | $34M | $0 | $-32.0K | $-10.0K | $68M | $282.0K | $23M | $-3M | $40M | $0 | $0 | $7M | $5M | $3M | |
| Pretax Income | $-644M | $-454M | $-365M | $-305M | $-248M | $-213M | $-195M | $-156M | $-133M | $-116M | $-161M | $-112M | $-98M | $-68M | $-57M | $-74M | |
| Income Tax | · | · | · | · | · | · | $-753.0K | $0 | $0 | $0 | $343.0K | $-4M | $0 | $0 | $-123.0K | $-297.0K | |
| Net Income | $-644M | $-454M | $-365M | $-305M | $-248M | $-213M | $-195M | $-156M | $-133M | $-116M | $-162M | $-108M | $-98M | $-68M | $-57M | $-73M | |
| EPS (Basic) | $-3.06 | $-2.29 | $-1.90 | $-1.61 | $-1.31 | $-1.13 | $-1.13 | $-0.94 | $-0.81 | $-0.70 | $-1.23 | $-0.99 | $-0.92 | $-0.72 | $-0.61 | $-0.87 | |
| EPS (Diluted) | $-3.06 | $-2.29 | $-1.90 | $-1.61 | $-1.31 | $-1.13 | $-1.13 | $-0.94 | $-0.81 | $-0.70 | $-1.23 | $-0.99 | $-0.92 | $-0.72 | $-0.61 | $-0.87 | |
| Shares (Basic) | 210,893,604 | 198,098,047 | -375,831,600 | 189,231,562 | 188,583,288 | 188,145,904 | -328,977,448 | 166,843,984 | 165,141,936 | 164,729,200 | -197,799,379 | 109,233,084 | 106,884,185 | 94,831,979 | -152,511,288 | 84,694,860 | |
| Shares (Diluted) | 210,893,604 | 198,098,047 | -375,831,600 | 189,231,562 | 188,583,288 | 188,145,904 | -328,977,448 | 166,843,984 | 165,141,936 | 164,729,200 | -197,799,379 | 109,233,084 | 106,884,185 | 94,831,979 | -152,511,288 | 84,694,860 | |
| EBITDA | $-505M | $-443M | · | $-315M | $-265M | $-239M | · | $-176M | $-157M | $-141M | · | $-123M | $-109M | $-74M | · | $-77M |
Bilanço 24
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $815M | $441M | $384M | $217M | $402M | $334M | $543M | $201M | $276M | $288M | $696M | $358M | $380M | $427M | $161M | $179M | |
| Short-term Investments | $3.12B | $1.47B | $1.64B | $1.71B | $1.73B | $1.77B | $1.75B | $1.35B | $1.32B | $1.42B | · | $455M | $529M | $483M | · | $476M | |
| Prepaid Expense | $90M | $60M | $49M | $46M | $39M | $32M | $38M | $30M | $34M | $26M | · | $11M | $10M | $9M | · | $15M | |
| Current Assets | $4.03B | $1.97B | $2.08B | $1.98B | $2.18B | $2.13B | $2.33B | $1.58B | $1.62B | $1.73B | · | $824M | $922M | $923M | · | $675M | |
| PP&E (Net) | $35M | $31M | $33M | $33M | $33M | $27M | $24M | $25M | $25M | $24M | · | $20M | $20M | $19M | · | $18M | |
| PP&E (Gross) | $67M | $62M | $62M | $60M | $58M | $51M | $46M | $46M | $46M | $43M | · | $38M | $37M | $34M | · | $32M | |
| Accum. Depreciation | $33M | $31M | $29M | $27M | $25M | $23M | $22M | $22M | $20M | $19M | · | $18M | $17M | $16M | · | $13M | |
| Goodwill | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $15M | $15M | $15M | · | $15M | |
| Intangibles | $56M | $56M | $56M | $56M | $56M | $56M | $57M | $57M | $57M | $57M | · | $58M | $58M | $59M | · | $59M | |
| Other Non-current Assets | $15M | $14M | $15M | $15M | $31M | $13M | $2M | $10M | $8M | $4M | · | $11M | $3M | $3M | · | $856.0K | |
| Total Assets | $4.32B | $2.25B | $2.35B | $2.25B | $2.43B | $2.37B | $2.56B | $1.76B | $1.81B | $1.91B | · | $984M | $1.07B | $1.07B | · | $826M | |
| Accounts Payable | $88M | $81M | $65M | $75M | $57M | $48M | $54M | $24M | $29M | $32M | · | $30M | $30M | $20M | · | $24M | |
| Accrued Liabilities | · | $5M | $5M | $5M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $354M | $290M | $290M | $246M | $185M | $159M | $164M | $111M | $105M | $94M | · | $86M | $78M | $55M | · | $73M | |
| Capital Leases | $138M | $140M | $142M | $142M | $120M | $121M | $123M | $78M | $79M | $80M | · | $57M | $58M | $58M | · | $58M | |
| Deferred Tax | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | · | $3M | $7M | $7M | · | $7M | |
| Other Non-current Liabilities | $2M | $7M | $1M | $2M | $7M | $4M | $670.0K | $2M | $656.0K | $3M | · | $982.0K | $252.0K | $2M | · | $471.0K | |
| Total Liabilities | $1.72B | $754M | $723M | $655M | $564M | $287M | $293M | $197M | $190M | $183M | · | $147M | $143M | $121M | · | $144M | |
| Common Stock | $21.0K | $19.0K | $19.0K | $18.0K | $18.0K | $18.0K | $18.0K | $16.0K | $16.0K | $16.0K | · | $11.0K | $11.0K | $11.0K | · | $9.0K | |
| Retained Earnings | $-3.97B | $-3.32B | $-2.87B | $-2.50B | $-2.20B | $-1.95B | $-1.74B | $-1.54B | $-1.39B | $-1.25B | · | $-976M | $-868M | $-769M | · | $-645M | |
| AOCI | $-6M | $-622.0K | $3M | $3M | $1M | $2M | $1M | $4M | $-2M | $-1M | · | $-871.0K | $-1M | $-556.0K | · | $-2M | |
| Stockholders' Equity | $2.61B | $1.50B | $1.63B | $1.60B | $1.87B | $2.08B | $2.27B | $1.57B | $1.62B | $1.73B | $1.83B | $837M | $931M | $952M | $685M | $681M | |
| Liabilities + Equity | $4.32B | $2.25B | $2.35B | $2.25B | $2.43B | $2.37B | $2.56B | $1.76B | $1.81B | $1.91B | · | $984M | $1.07B | $1.07B | · | $826M | |
| Shares Outstanding | 214,242,688 | 200,178,626 | 197,001,401 | 189,710,951 | 186,901,268 | 186,258,206 | 185,896,625 | 167,748,336 | 165,646,508 | 164,913,014 | · | 109,451,685 | 109,141,094 | 106,298,077 | · | 87,815,287 |
Nakit Akışı 12
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | $1M | $1M | $1M | $991.0K | |
| Stock-based Comp | $67M | $87M | $34M | $31M | $29M | $25M | $22M | $21M | $20M | $16M | $25M | $14M | $13M | $10M | $8M | $8M | |
| Amort. of Intangibles | $0 | $0 | $3.0K | $300.0K | $300.0K | $267.0K | $202.0K | $300.0K | $300.0K | $267.0K | $201.0K | $300.0K | $300.0K | $267.0K | $202.0K | $300.0K | |
| Other Non-cash | · | $10M | · | · | · | $-8M | · | · | · | · | · | · | · | $-5M | · | · | |
| Operating Cash Flow | $-387M | $-354M | $-274M | $-207M | $-222M | $-194M | $-138M | $-130M | $-128M | $-161M | $-121M | $-100M | $-67M | $-62M | $-62M | $-52M | |
| CapEx | $2M | $2M | $2M | $3M | $7M | $3M | $1M | $4M | $2M | $3M | $2M | $3M | $1M | $2M | $3M | $4M | |
| Investing Cash Flow | $-1.66B | $173M | $75M | $25M | $34M | $-16M | $-393M | $-21M | $108M | $-248M | $-380M | $77M | $-44M | $4M | $-7M | $-123M | |
| Stock Issued | · | · | · | · | · | · | $728M | $0 | $0 | $0 | $0 | $0 | $0 | $324M | $0 | $248M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $324M | · | · | |
| Financing Cash Flow | $2.42B | $239M | $366M | $-2M | $257M | $874.0K | $874M | $77M | $8M | $810.0K | $839M | $1M | $65M | $324M | $51M | $248M | |
| Net Change in Cash | $374M | $57M | $166M | $-184M | $69M | $-210M | $343M | $-75M | $-13M | $-408M | $338M | $-22M | $-46M | $266M | $-18M | $73M | |
| Free Cash Flow | · | $-356M | · | · | · | $-198M | · | · | · | $-164M | · | · | · | $-64M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | -2845.1% | -1071.5% | · | -2280.5% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | -2570.6% | -970.9% | · | -2185.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | -2570.6% | -970.9% | · | -2193.9% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | -2845.1% | -1054.3% | · | -2280.5% | |
| ROA | -19.1% | -19.7% | · | -15.2% | -11.7% | -10.0% | · | -11.4% | -10.9% | -7.8% | · | -12.0% | · | -7.8% | · | -9.4% | |
| ROE | -28.8% | -25.4% | · | -19.3% | -14.2% | -11.2% | · | -13.0% | -12.6% | -8.7% | · | -14.3% | · | -9.1% | · | -11.1% | |
| ROIC | · | · | · | · | · | · | · | -11.2% | -9.7% | -8.2% | · | -14.2% | · | -7.9% | · | -11.2% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.4 | 6.8 | · | 8.1 | 11.8 | 13.5 | · | 14.2 | 15.4 | 18.5 | · | 9.6 | · | 16.9 | · | 9.2 | |
| Quick Ratio | 11.1 | 6.6 | · | 7.9 | 11.6 | 13.3 | · | 14.0 | 15.1 | 18.2 | · | 9.5 | · | 16.7 | · | 8.9 |
Verimlilik 1
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | 0.0 | · | 0.0 |
Değerleme (TTM) 9
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $4M | $11M | · | $14M | $23M | $27M | · | $21M | |
| Net Income TTM | $-1.65B | $-1.22B | · | $-923M | $-751M | $-619M | · | $-514M | $-456M | $-391M | · | $-348M | $-301M | $-260M | · | $-245M | |
| Market Cap | $403M | $376M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.2 | -0.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.2 | 0.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.2 | 0.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -1.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | · | -1.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -439.9% | -337.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $0 | $0 | $12M | $35M | $29M |
| Faaliyet Kâr Marjı % | — | — | -4207.1% | -730.0% | -639.7% |
| Net Gelir | $-1.13B | $-600M | $-436M | $-249M | $-187M |
| Seyreltilmiş Hisse Başı Kâr | $-5.95 | $-3.58 | $-3.86 | $-3.08 | $-2.57 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 7.1 | 14.2 | 13.1 | 10.7 | 9.8 |
| Cari Oran | 7.0 | 14.0 | 12.9 | 10.4 | 9.6 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-914M | $-568M | $-358M | $-235M | $-154M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 23 dosya · $93.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 5 (+3 önceki Ç'ye göre) | 3 (0 önceki Ç'ye göre) | 3 (-2 önceki Ç'ye göre) | 3 (-3 önceki Ç'ye göre) | +606K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| LMR Partners LLP | $47.524.183 | 5.066.598 | 50,88% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $14.855.243 | 1.580.345 | 15,90% | Hisse senetleri |
| CSS LLC/IL | $6.610.382 | 78.367 | 7,08% | Hisse senetleri |
| Caption Management, LLC | $4.855.834 | 517.685 | 5,20% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.689.950 | 500.000 | 5,02% | Hisse senetleri |
| Rangeley Capital, LLC | $4.682.000 | 25.000 | 5,01% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $2.344.975 | 250.000 | 2,51% | Hisse senetleri |
| Bleichroeder LP | $1.875.980 | 200.000 | 2,01% | Hisse senetleri |
| WOLVERINE ASSET MANAGEMENT LLC | $1.449.607 | 154.544 | 1,55% | Hisse senetleri |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $1.128.799 | 120.085 | 1,21% | Hisse senetleri |
| Warberg Asset Management LLC | $889.186 | 94.797 | 0,95% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $814.438 | 86.828 | 0,87% | Alım opsiyonu |
| Weiss Asset Management LP | $692.216 | 73.640 | 0,74% | Hisse senetleri |
| TD Asset Management Inc | $381.978 | 40.636 | 0,41% | Hisse senetleri |
| Sculptor Capital LP | $362.674 | 38.665 | 0,39% | Hisse senetleri |
| Driehaus Capital Management LLC | $188.000 | 20.000 | 0,20% | Hisse senetleri |
| UBS Group AG | $23.084 | 2.461 | 0,02% | Hisse senetleri |
| MORGAN STANLEY | $20.786 | 2.216 | 0,02% | Hisse senetleri |
| DLK Investment Management, LLC | $7.862 | 77.000 | 0,01% | Hisse senetleri |
| PRICE T ROWE ASSOCIATES INC /MD/ | $5.448 | 579.550 | 0,01% | Hisse senetleri |
| TD Waterhouse Canada Inc. | $4.118 | 448 | 0,00% | Hisse senetleri |
| ROYAL BANK OF CANADA | $2.000 | 200 | 0,00% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $187 | 20 | 0,00% | Hisse senetleri |
Şirket yöneticileri 13 içeriden öğrenenler · 6 yöneticiler · 8 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Mark A Goldsmith | President and Chief Executive Officer | 16 Haziran 2026 S | 267.330 | 0 | 1 | $-1.564.322 |
| Jack Anders | Chief Financial Officer | 24 Haziran 2026 M | 123.269 | 0 | 5 | $-3.791.556 |
| Stephen Michael Kelsey | President, Research and Development | 16 Haziran 2026 S | 291.876 | 0 | 1 | $-651.801 |
| Margaret A Horn | Chief Operating Officer | 17 Haziran 2026 M | 154.647 | 0 | 10 | $-16.452.072 |
| Anthony Mancini | Chief Global Commercialization Officer | 16 Haziran 2026 S | 49.975 | 0 | 1 | $-720.494 |
| Jeff Cislini | General Counsel | 16 Haziran 2026 S | 56.521 | 0 | 1 | $-336.751 |
| Sushil Patel | Yönetim kurulu üyesi | 29 Haziran 2026 M | 21.656 | 0 | 9 | $-1.048.970 |
| Flavia Borellini | Yönetim kurulu üyesi | 18 Haziran 2026 A | 26.215 | 0 | 0 | $0 |
| Frank Clyburn | Yönetim kurulu üyesi | 18 Haziran 2026 A | 10.929 | 0 | 0 | $0 |
| Elizabeth M Anderson | Yönetim kurulu üyesi | 18 Haziran 2026 A | 9.406 | 0 | 0 | $0 |
| Lorence H. Kim | Yönetim kurulu üyesi | 18 Haziran 2026 A | 74.281 | 0 | 0 | $0 |
| Sandra Horning | Yönetim kurulu üyesi | 18 Haziran 2026 A | 97.765 | 0 | 0 | $0 |
| Alexis Borisy | Yönetim kurulu üyesi | 18 Haziran 2026 A | 2.340.075 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış